Premium
Reduction of pulmonary exacerbations in young children with cystic fibrosis during the COVID‐19 pandemic
Author(s) -
Patel Shreya,
Thompson Misty D.,
Slaven James E.,
Sanders Don B.,
Ren Clement L.
Publication year - 2021
Publication title -
pediatric pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 106
eISSN - 1099-0496
pISSN - 8755-6863
DOI - 10.1002/ppul.25250
Subject(s) - medicine , cystic fibrosis , covid-19 , pandemic , respiratory system , pulmonary fibrosis , retrospective cohort study , pediatrics , intensive care medicine , lung , virology , disease , outbreak , infectious disease (medical specialty)
To assess the impact of COVID‐19 restrictions on cystic fibrosis (CF) pulmonary exacerbations (PEx) we performed a retrospective review of PEx events at our CF Center and compared the rate of PEx in 2019 versus 2020. Restrictions on social interaction due to the COVID‐19 pandemic were associated with a lower number of PEx events at our pediatric CF Center, suggesting that these restrictions also reduced exposure to other respiratory viral infection in children with CF.